The safety and efficacy evaluation of Sodium-Glucose co-transporter 2 inhibitors for patients with non-alcoholic fatty Liver disease: An updated meta-analysis

In recent years, sodium-glucose co-transporter 2 inhibitors (SGLT2is) have been increasingly used in the treatment of patients with non-alcoholic fatty liver disease (NAFLD). This updated meta-analysis aimed to evaluate the efficacy and safety of SGLT2is for patients with NAFLD.

https://www.dldjournalonline.com/article/S1590-8658(21)00733-7/fulltext?rss=yes

Source: Digestive and Liver Disease - September 7, 2021 Category: Gastroenterology Authors: Manqiu Mo, Zichun Huang, Yuzhen Liang, Yunhua Liao, Ning Xia Tags: Meta-Analysis Source Type: research